<DOC>
	<DOCNO>NCT00955981</DOCNO>
	<brief_summary>To compare proportion subject whose serum urate ( sUA ) level &lt; 6.0 mg/dL 28 day dose treatment group .</brief_summary>
	<brief_title>Gout Dose Response Study</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Lesinurad</mesh_term>
	<criteria>Male postmenopausal surgically sterile female . 18 75 year age . Hyperuricemic ( i.e. , screen sUA â‰¥8 mg/dL ) . Meets criteria diagnosis gout per American Rheumatism Association ( ARA ) Criteria Classification Acute Arthritis Primary Gout . Willing able give inform consent adhere visit/protocol schedule ( informed consent must give first study procedure perform ) . Subjects enter optional Extension Period must successfully complete DoubleBlind Treatment Period Followup Period within approximately 4 month must experience serious adverse event consider possibly relate study drug . Classified overproducer urine urate ( Cur &gt; 6.0 ml/min/1.73 m2 24 hour urine ) . Consumes 14 drink alcohol per week ( e.g. , 1 drink = 5 oz [ 150 ml ] wine , 12 oz [ 360 ml ] beer , 1.5 oz [ 45 ml ] hard liquor ) . History suspicion drug abuse . Documented history suspicion kidney stone . History rheumatoid arthritis autoimmune disease . Confirmed ( positive serology HIV1 HIV 2 ) suspect HIV infection . Positive serology HCV antibody ( Abs ) , and/or hepatitis B surface antigen ( HBsAg ) . History malignancy , except treat nonmelanomatous skin cancer cervical dysplasia . History cardiac abnormality , include abnormal clinically relevant ECG change bradycardia ( sinus rate &lt; 45 bpm ) , complete leave bundle branch block ( LBBB ) , second third degree heart block , intraventricular conduction delay QRS duration &gt; 120 msec , symptomatic asymptomatic arrhythmia exception sinus arrhythmia , evidence ventricular preexcitation , frequent palpitation syncopal episode , heart failure , hypokalemia , family history Long QT Syndrome , and/or family history sudden death otherwise healthy individual age 1 30 year . Any condition predispose QT prolongation include pathological Qwave ( define Qwave &gt; 40 msec depth &gt; 0.40.5 mV ) . Any use concomitant medication prolong QT/QTc interval within 14 day prior Baseline ( Day 0 ) QT interval correct heart rate accord Fridericia ( QTcF ) &gt; 450 msec Screening predose Baseline ( Day 0 ) Uncontrolled hypertension ( 150/95 ) Inadequate renal function Hemoglobin &lt; 10 g/dL ( male ) &lt; 9 g/dL ( female ) Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 2.5 x upper limit normal ( ULN ) Gamma glutamyl transferase ( GGT ) &gt; 3 x ULN Active peptic ulcer disease require treatment History xanthinuria , active liver disease , hepatic dysfunction . Requires therapy uratelowering medication , study medication . Requires longterm use salicylate ; diuretic ; azathioprine ; mercaptopurine ; theophylline ; intravenous colchicine ; cyclosporine ; cyclophosphamide ; pyrazinamide ; sulfamethoxazole ; trimethoprim Taking medication know enzyme inducer Receiving strong moderate inhibitor CYP3A4 Pgp inhibitor within 1 month prior study drug dose Gout flare screen resolve less one week prior first treatment study medication ( exclusive chronic synovitis/ arthritis ) Female childbearing potential Received investigational medication within 4 week prior study medication administration Previously participate clinical study involve RDEA806 RDEA594 . Known hypersensitivity allergy RDEA594 colchicine component formulation . Body mass index ( BMI ) &gt; 40 kg/m2 . Taking great 1000 mg/day Vitamin C. Any medical psychological condition , opinion Investigator and/or Medical Monitor , might create undue risk subject interfere subject 's ability comply protocol requirement , complete study . Inadequate renal function complete DoubleBlind Treatment period prior enter Extension Period . Requiring treatment prohibit medication note exclusion criterion number 2023 complete DoubleBlind Treatment Period prior enter Extension Period . Clinically relevant medical event determine investigator consultation medical monitor prior enter Extension Period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>